{"doc_id": "PMID-10101034.txt", "sent_id": "S1", "tokens": ["Inhibition", "of", "cyclooxygenase-2", "expression", "by", "4-trifluoromethyl", "derivatives", "of", "salicylate", ",", "triflusal", ",", "and", "its", "deacetylated", "metabolite", ",", "2-hydroxy-4-trifluoromethylbenzoic", "acid", "."], "sentence": "Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate , triflusal , and its deacetylated metabolite , 2-hydroxy-4-trifluoromethylbenzoic acid .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "Inhibition", "start": 0, "end": 0}, "arguments": [{"entity_id": "T12", "text": "expression", "role": "Theme"}]}, {"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 3, "end": 3}, "arguments": [{"entity_id": "T1", "text": "cyclooxygenase-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "cyclooxygenase-2", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T11", "text": "Inhibition", "entity_type": "Negative_regulation", "start": 0, "end": 0}, {"id": "T12", "text": "expression", "entity_type": "Gene_expression", "start": 3, "end": 3}]}
{"doc_id": "PMID-10101034.txt", "sent_id": "S2", "tokens": ["The", "therapeutic", "potential", "of", "drugs", "that", "block", "the", "induction", "of", "cyclooxygenase-2", "has", "been", "emphasized", "."], "sentence": "The therapeutic potential of drugs that block the induction of cyclooxygenase-2 has been emphasized .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "cyclooxygenase-2", "entity_type": "Protein", "start": 10, "end": 10}]}
{"doc_id": "PMID-10101034.txt", "sent_id": "S3", "tokens": ["When", "two", "4-trifluoromethyl", "salicylate", "derivatives", "[", "2-acetoxy-4-trifluoromethyl-benzoic", "acid", "(", "triflusal", ")", "and", "its", "deacetylated", "metabolite", "2-hydroxy-4-trifluoromethylbenzoic", "acid", "(", "HTB", ")", "]", "were", "compared", "with", "aspirin", "and", "sodium", "salicylate", "as", "cyclooxygenase-2", "(", "COX-2", ")", "inhibitors", ",", "we", "observed", "that", "in", "bacterial", "lipopolysaccharide", "-", "activated", "human", "blood", ",", "triflusal", ",", "aspirin", ",", "and", "HTB", ",", "but", "not", "sodium", "salicylate", ",", "inhibited", "COX-2", "-", "mediated", "prostaglandin", "E2", "(", "PGE2", ")", "production", "(", "IC50", "=", "0.16", ",", "0.18", ",", "0.39", ",", "and", ">", "10", "mM", ",", "respectively", ")", "."], "sentence": "When two 4-trifluoromethyl salicylate derivatives [ 2-acetoxy-4-trifluoromethyl-benzoic acid ( triflusal ) and its deacetylated metabolite 2-hydroxy-4-trifluoromethylbenzoic acid ( HTB ) ] were compared with aspirin and sodium salicylate as cyclooxygenase-2 ( COX-2 ) inhibitors , we observed that in bacterial lipopolysaccharide - activated human blood , triflusal , aspirin , and HTB , but not sodium salicylate , inhibited COX-2 - mediated prostaglandin E2 ( PGE2 ) production ( IC50 = 0.16 , 0.18 , 0.39 , and > 10 mM , respectively ) .", "event_mentions": [], "entity_mentions": [{"id": "T3", "text": "cyclooxygenase-2", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T4", "text": "COX-2", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T5", "text": "COX-2", "entity_type": "Protein", "start": 59, "end": 59}]}
{"doc_id": "PMID-10101034.txt", "sent_id": "S4", "tokens": ["However", ",", "only", "triflusal", "and", "aspirin", "inhibited", "purified", "COX-2", "enzyme", "."], "sentence": "However , only triflusal and aspirin inhibited purified COX-2 enzyme .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "inhibited", "start": 6, "end": 6}, "arguments": [{"entity_id": "T6", "text": "COX-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T6", "text": "COX-2", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T13", "text": "inhibited", "entity_type": "Negative_regulation", "start": 6, "end": 6}]}
{"doc_id": "PMID-10101034.txt", "sent_id": "S5", "tokens": ["To", "test", "this", "apparent", "discrepancy", ",", "we", "realized", "that", "HTB", "and", "triflusal", "(", "but", "neither", "aspirin", "nor", "salicylate", ")", "produced", "a", "concentration", "-", "dependent", "inhibition", "of", "COX-2", "protein", "expression", "in", "peripheral", "human", "mononuclear", "cells", "."], "sentence": "To test this apparent discrepancy , we realized that HTB and triflusal ( but neither aspirin nor salicylate ) produced a concentration - dependent inhibition of COX-2 protein expression in peripheral human mononuclear cells .", "event_mentions": [{"id": "E4", "event_type": "Positive_regulation", "trigger": {"text": "produced", "start": 19, "end": 19}, "arguments": [{"entity_id": "T15", "text": "inhibition", "role": "Theme"}]}, {"id": "E5", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 24, "end": 24}, "arguments": [{"entity_id": "T16", "text": "expression", "role": "Theme"}]}, {"id": "E6", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 28, "end": 28}, "arguments": [{"entity_id": "T7", "text": "COX-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T7", "text": "COX-2", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T14", "text": "produced", "entity_type": "Positive_regulation", "start": 19, "end": 19}, {"id": "T15", "text": "inhibition", "entity_type": "Negative_regulation", "start": 24, "end": 24}, {"id": "T16", "text": "expression", "entity_type": "Gene_expression", "start": 28, "end": 28}]}
{"doc_id": "PMID-10101034.txt", "sent_id": "S6", "tokens": ["This", "observation", "was", "further", "confirmed", "in", "a", "rat", "air", "pouch", "model", "in", "vivo", ",", "in", "which", "both", "aspirin", "and", "triflusal", "inhibited", "PGE2", "production", "(", "ID50", "=", "18.9", "and", "11.4", "mg", "/", "kg", "p.o", ".", ",", "respectively", ")", "but", "only", "triflusal", "-", "treated", "animals", "showed", "a", "decrease", "in", "COX-2", "expression", "."], "sentence": "This observation was further confirmed in a rat air pouch model in vivo , in which both aspirin and triflusal inhibited PGE2 production ( ID50 = 18.9 and 11.4 mg / kg p.o . , respectively ) but only triflusal - treated animals showed a decrease in COX-2 expression .", "event_mentions": [{"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "decrease", "start": 45, "end": 45}, "arguments": [{"entity_id": "T18", "text": "expression", "role": "Theme"}]}, {"id": "E8", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 48, "end": 48}, "arguments": [{"entity_id": "T8", "text": "COX-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T8", "text": "COX-2", "entity_type": "Protein", "start": 47, "end": 47}, {"id": "T17", "text": "decrease", "entity_type": "Negative_regulation", "start": 45, "end": 45}, {"id": "T18", "text": "expression", "entity_type": "Gene_expression", "start": 48, "end": 48}]}
{"doc_id": "PMID-10101034.txt", "sent_id": "", "tokens": ["This", "different", "behavior", "may", "be", ",", "at", "least", "in", "part", ",", "due", "to", "the", "ability", "of", "HTB", "and", "triflusal", "to", "block", "the", "activation", "of", "the", "transcription", "factor", "nuclear", "factor-kappaB", "to", "a", "higher", "extent", "than", "aspirin", "and", "sodium", "salicylate", "."], "sentence": "This different behavior may be , at least in part , due to the ability of HTB and triflusal to block the activation of the transcription factor nuclear factor-kappaB to a higher extent than aspirin and sodium salicylate .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10101034.txt", "sent_id": "S8", "tokens": ["Thus", ",", "in", "addition", "to", "inhibiting", "the", "COX-2", "activity", "at", "therapeutic", "concentrations", ",", "triflusal", "is", "able", "to", "block", "through", "its", "metabolite", "HTB", "the", "expression", "of", "new", "enzyme", ",", "and", "hence", "the", "resumption", "of", "PGE2", "synthesis", "."], "sentence": "Thus , in addition to inhibiting the COX-2 activity at therapeutic concentrations , triflusal is able to block through its metabolite HTB the expression of new enzyme , and hence the resumption of PGE2 synthesis .", "event_mentions": [], "entity_mentions": [{"id": "T9", "text": "COX-2", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T19", "text": "block", "entity_type": "Negative_regulation", "start": 17, "end": 17}, {"id": "T20", "text": "expression", "entity_type": "Gene_expression", "start": 23, "end": 23}]}
{"doc_id": "PMID-10101034.txt", "sent_id": "S9", "tokens": ["Triflusal", "and", "HTB", "may", "exert", "beneficial", "effects", "in", "processes", "in", "which", "de", "novo", "COX-2", "expression", "is", "involved", "and", ",", "in", "a", "broader", "sense", ",", "in", "pathological", "situations", "in", "which", "genes", "under", "nuclear", "factor-kappaB", "control", "are", "up-regulated", "."], "sentence": "Triflusal and HTB may exert beneficial effects in processes in which de novo COX-2 expression is involved and , in a broader sense , in pathological situations in which genes under nuclear factor-kappaB control are up-regulated .", "event_mentions": [{"id": "E11", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 14, "end": 14}, "arguments": [{"entity_id": "T10", "text": "COX-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T10", "text": "COX-2", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T21", "text": "expression", "entity_type": "Gene_expression", "start": 14, "end": 14}]}
